Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Echinobase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Echinobase
ECB-ART-50292
Development 2022 Jun 01;14911:. doi: 10.1242/dev.200644.
Show Gene links Show Anatomy links

Generation of a homozygous mutant drug transporter (ABCB1) knockout line in the sea urchin Lytechinus pictus.

Vyas H , Schrankel CS , Espinoza JA , Mitchell KL , Nesbit KT , Jackson E , Chang N , Lee Y , Warner J , Reitzel A , Lyons DC , Hamdoun A .


???displayArticle.abstract???
Sea urchins are premier model organisms for the study of early development. However, the lengthy generation times of commonly used species have precluded application of stable genetic approaches. Here, we use the painted sea urchin Lytechinus pictus to address this limitation and to generate a homozygous mutant sea urchin line. L. pictus has one of the shortest generation times of any currently used sea urchin. We leveraged this advantage to generate a knockout mutant of the sea urchin homolog of the drug transporter ABCB1, a major player in xenobiotic disposition for all animals. Using CRISPR/Cas9, we generated large fragment deletions of ABCB1 and used these readily detected deletions to rapidly genotype and breed mutant animals to homozygosity in the F2 generation. The knockout larvae are produced according to expected Mendelian distribution, exhibit reduced xenobiotic efflux activity and can be grown to maturity. This study represents a major step towards more sophisticated genetic manipulation of the sea urchin and the establishment of reproducible sea urchin animal resources.

???displayArticle.pubmedLink??? 35666622
???displayArticle.pmcLink??? PMC9245184
???displayArticle.link??? Development
???displayArticle.grants??? [+]



???attribute.lit??? ???displayArticles.show???
References [+] :
Begicevic, ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance. 2017, Pubmed